CareMax — Q2 2023 Earnings Presentation
16 slides from CareMax's earnings presentation, Aug 9, 2023
Slide 1: Second Quarter 2023 Earnings Presentation
Second Quarter 2023 Earnings Presentation August 9, 2023 EX-99.2
Slide 2: Disclaimer
Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or
Slide 3: CareMax is Driven by a Mission to Deliver Best-in-Class Care
CareMax is Driven by a Mission to Deliver Best-in-Class Care 102K+ Medicare Advantage Members 62 CareMax Medical Centers 5-Stars CMS Quality Rating1 272K+ Total Members 10 States Note: As of June 30, 2023. Centers for Medicare & Medicaid Services 2022 Star rating across CareMax centers as of year-en
Slide 4: Second Quarter 2023 Update
Second Quarter 2023 Update Total membership of 272,500, up 210% year-over year Medicare Advantage membership of 102,500, up 177% year-over-year Revenue of $224.4 million, up 30% year-over-year Net loss of $32.4 million, compared to net loss of $9.4 million for 2Q22 Adjusted EBITDA of $7.0 million, c
Slide 5: Membership Breakdown
Membership Breakdown Total Membership 272,500 Lives ~102,500 Medicare Advantage1 Full-Risk 36% Other VBC2 64% ~30,500 Medicaid Other VBC2 97% ~38,500 Commercial Full-Risk 90% Other VBC2 10% ~101,000 MSSP & ACO REACH MSSP 92% ACO REACH 8% Note: As of June 30, 2023. 99% of MA patients in value-based a
Slide 6: Revising Revenue Outlook for Full Year 2023
Revising Revenue Outlook for Full Year 2023 Note: Year over year growth may not compute due to rounding. Adjusted EBITDA is a non-GAAP number. For a reconciliation to the closest GAAP number, see supplement to this presentation. A reconciliation of projected 2023 Adjusted EBITDA to the most directly
Slide 7: Second Quarter 2023 Financial Supplement
Second Quarter 2023 Financial Supplement
Slide 8: Reconciliation to Platform Contribution and Calculation of Medical Expense Ratio
Reconciliation to Platform Contribution and Calculation of Medical Expense Ratio Gross profit reflects the reclassification of stock-based compensation expense previously included in corporate, general and administrative expenses, which decreased gross profit by $1.3 million for the three months end
Slide 9: Reconciliation to Adjusted EBITDA
Reconciliation to Adjusted EBITDA1 Net Income to Adjusted EBITDA Bridge Beginning with the three months ended June 30, 2023, for all periods presented, the Company has updated its calculation of the reconciliation of Adjusted EBITDA on a retrospective basis to no longer add back certain compensation
Slide 10: Non-GAAP Adjustments Detail
Non-GAAP Adjustments Detail a) Represents consulting and legal costs directly associated with efforts related to integration of the two privately held companies that were combined in the Business Combination. b) Represents primarily vendor expenses identified as temporary or duplicative and/or expen
Slide 11: Non-GAAP Adjustments Detail
Non-GAAP Adjustments Detail Components of Pro forma adjustments
Slide 12: Non-GAAP Financial Summary
Non-GAAP Financial Summary Beginning with the three months ended June 30, 2023, for all periods presented, the Company has updated its calculation of the reconciliation of Adjusted EBITDA on a retrospective basis to no longer add back certain compensation costs for stay-on bonuses and duplicative sa
Slide 13: Financial Impact of Prior Year Developments
Financial Impact of Prior Year Developments The first half of 2023 was also impacted by approximately $3.5 million of other favorable prior year developments in total revenue and approximately $3.3 million of other unfavorable prior year development in external provider costs. Related to retrospecti
Slide 14: Illustrative Underlying CareMax Centers Medical Expense Ratio
Illustrative Underlying CareMax Centers Medical Expense Ratio Medical Expense Ratio equals external provider costs divided by Medicare and Medicaid risk-based revenues. See prior page for summary of select prior year developments. Reflects dilutive impact of full risk MSO membership on MER. 1H23 und
Slide 15: Capitalization and Liquidity as of June 30, 2023
Capitalization and Liquidity as of June 30, 2023 Diluted Share Count Net Debt (Cash) Excludes unvested warrants as of June 30, 2023. Warrants have a strike price of $11.50 per share and (other than the Related warrants) are subject to a $18.00 redemption cap. Warrants are currently out of the money
Slide 16: Q&A
Care Max Q&A